Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Ventyx Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 150 | 2 | 138 | −10 |
| Shares | 52.7M | 798.5K | 54.6M | +2.73M (+5.3%) |
| Value | $1.73B | $26.2M | $1.90B | +$195.6M (+11.5%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Ventyx Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 969,979 | $33.7M | 0.04% |
| Balyasny Asset Management LLC | 217,151 | $7.54M | 0.02% |
| Sectoral Asset Management Inc | 88,000 | $3.06M | 0.60% |
| Tiaa Trust, National Association | 41,875 | $1.45M | 0.01% |
| Ghost Tree Capital, LLC | 35,000 | $1.22M | 0.59% |
| Endurant Capital Management LP | 18,458 | $641.0K | 0.58% |
| AlphaCentric Advisors LLC | 12,000 | $416.8K | 0.24% |
| Mariner, LLC | 7,128 | $247.6K | 0.00% |
| Rafferty Asset Management, LLC | 6,017 | $209.0K | 0.00% |
| JSF Financial, LLC | 6,000 | $208.4K | 0.08% |
| BIT Capital GmbH | 1,969 | $68.4K | 0.01% |
| KBC Group NV | 644 | $22.0K | 0.00% |
| Bell Investment Advisors, Inc | 15 | $521 | 0.00% |
Sold out (23)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 617,000 | $20.2M |
| HSBC Holdings PLC | 249,273 | $8.23M |
| Affinity Asset Advisors, LLC | 100,696 | $3.30M |
| Tri Locum Partners LP | 57,800 | $1.90M |
| D. E. Shaw & Co., Inc. | 47,112 | $1.55M |
| MPM Oncology Impact Management LP | 31,747 | $1.04M |
| Silverarc Capital Management, LLC | 25,000 | $820.0K |
| Diametric Capital, LP | 24,131 | $791.5K |
| HRT Financial LP | 22,397 | $734.0K |
| Soleus Capital Management, L.P. | 21,300 | $698.6K |
| Susquehanna International Group, LLP | 13,219 | $433.6K |
| Franklin Resources Inc | 13,119 | $430.3K |
| Squarepoint Ops LLC | 10,087 | $330.9K |
| Seven Eight Capital, LP | 9,184 | $301.2K |
| Moran Wealth Management, LLC | 8,312 | $272.6K |
| Two Sigma Advisers, LP | 8,200 | $269.0K |
| STRS Ohio | 8,200 | $268.0K |
| Prelude Capital Management, LLC | 7,746 | $254.1K |
| NinePointTwo Capital | 7,741 | $253.0K |
| ExodusPoint Capital Management, LP | 6,994 | $229.0K |
| Cubist Systematic Strategies, LLC | 4,179 | $137.1K |
| TD Waterhouse Canada Inc. | 1,060 | $42.3K |
| Allspring Global Investments Holdings, LLC | 456 | $15.0K |
Not filed for Q3 2023 yet (2)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 756,656 | $24.8M |
| Tiaa, FSB | 41,876 | $1.37M |